General Steel Holdings, Inc. (GSIH)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
General Steel Holdings, Inc. (GSIH) trades at $0.00. General Steel Holdings, Inc. operates in the cell research and development sector within the People's Republic of China. The company focuses on cell storage and culture services. Market cap: $13,804, Sector: Basic materials.
Price live · AI analysis from Mar 17, 2026Analyst Coverage for GSIH: GSIH does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates GSIH against Basic Materials peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
GSIH: 1/1 perspectives are bearish.
How is this calculated? →General Steel Holdings, Inc. (GSIH) Materials & Commodity Exposure
General Steel Holdings, Inc., headquartered in Beijing, China, is engaged in cell research, development, storage, and cell culture services. With a small team, the company operates within the Basic Materials sector, specifically focusing on innovative cell-based solutions in the Chinese market.
What Is the Investment Thesis for GSIH?
Investing in General Steel Holdings, Inc. presents a highly speculative opportunity given its small market capitalization of 14K and negative P/E ratio of -0.02. The company's focus on cell research and development in China could offer growth potential if it can successfully commercialize its technologies. However, the negative beta of -7.42 suggests extreme volatility. Key value drivers would include securing research grants, partnerships, or successful product launches. The absence of a dividend indicates a focus on reinvesting earnings, but the company's financial viability needs careful assessment. The OTC market listing introduces additional risks related to liquidity and transparency.
Based on FMP financials and quantitative analysis
GSIH Key Highlights
- Market capitalization of 14K indicates a micro-cap company with limited market presence.
- Negative P/E ratio of -0.02 suggests the company is currently not profitable.
- Beta of -7.42 indicates extreme volatility relative to the market.
- No dividend yield reflects a focus on reinvesting earnings for growth.
- Operations are based in China, exposing the company to regulatory and economic factors specific to that region.
Who Are GSIH's Competitors?
GSIH is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| FEEXY Ferrexpo plc | $1.65 | +0.00% | $242.70M | 54 |
| FEEXF Ferrexpo plc | $0.39 | +0.00% | $228.65M | 54 |
| MSB Mesabi Trust | $25.89 | +1.17% | $339.68M | 53 |
| APMSF Aperam S.A. | $44.70 | +0.00% | $3.23B | 52 |
| AMSIY ArcelorMittal South Africa Ltd | $0.13 | -23.24% | $246.53M | 41 |
| MTGRY MGX Resources Limited | $2.85 | +0.88% | $3.43B | 41 |
| CISXF China Steel Corporation | $19.87 | +33.36% | $15.14B | 41 |
| CKSNY Vesuvius plc | $6.36 | +10.61% | $1.57B | 42 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are GSIH's Key Strengths?
- Focus on cell research and development.
- Location in Beijing, China.
- Potential for innovation in biotechnology.
- Cell storage and culture services
What Are GSIH's Weaknesses?
- Small size and limited resources.
- Negative profitability.
- High volatility.
- OTC market listing.
What Could Drive GSIH Stock Higher?
- Potential research grants or funding from government agencies.
- Partnerships with research institutions to develop new cell-based technologies.
- Successful clinical trials or regulatory approvals for cell therapies.
- Expansion of cell storage facilities and services.
- Increasing demand for cell-based therapies and regenerative medicine.
What Are the Key Risks for GSIH?
- Negative return on equity (-19.6%) — the business is not currently generating profit on shareholder capital.
- Insider selling — insiders were net sellers of roughly $1.0M recently.
- Competition from larger, more established biotechnology companies.
- Regulatory changes in China affecting the biotechnology sector.
- Economic downturns impacting research funding and healthcare spending.
- Limited financial resources and negative profitability.
- High volatility and liquidity risks associated with OTC market listing.
What Are the Growth Opportunities for GSIH?
- Expansion into Cell-Based Therapies: The increasing demand for cell-based therapies presents a significant growth opportunity. By focusing on developing and commercializing innovative cell therapies, General Steel Holdings can tap into a rapidly expanding market. The global cell therapy market is projected to reach billions of dollars in the coming years, offering substantial revenue potential. Timeline: 3-5 years for product development and regulatory approvals.
- Strategic Partnerships with Research Institutions: Collaborating with leading research institutions in China can accelerate the development of new cell-based technologies. These partnerships can provide access to cutting-edge research, expertise, and funding opportunities. By establishing strong relationships with research institutions, General Steel Holdings can enhance its innovation capabilities. Timeline: Ongoing.
- Government Funding and Grants: Securing government funding and grants for cell research and development projects can provide crucial financial support. The Chinese government is actively promoting innovation in the biotechnology sector, offering various funding programs. By successfully obtaining these grants, General Steel Holdings can reduce its financial burden and accelerate its research efforts. Timeline: Ongoing.
- Expansion of Cell Storage Services: The growing demand for cell storage services, driven by advancements in regenerative medicine and personalized healthcare, presents a valuable growth opportunity. By expanding its cell storage facilities and offering specialized storage solutions, General Steel Holdings can cater to the needs of research institutions, hospitals, and pharmaceutical companies. Timeline: 2-3 years for infrastructure development.
- International Expansion: Expanding its operations beyond China can provide access to new markets and customers. By establishing partnerships or subsidiaries in other countries, General Steel Holdings can diversify its revenue streams and reduce its reliance on the Chinese market. This expansion can also enhance its global brand recognition and attract international talent. Timeline: 5+ years for market research and entry.
What Opportunities Does GSIH Have?
- Expansion into cell-based therapies.
- Strategic partnerships with research institutions.
- Government funding and grants.
- Growth in cell storage services.
What Threats Does GSIH Face?
- Competition from larger biotechnology companies.
- Regulatory changes in China.
- Economic downturns.
- Technological obsolescence.
What Are GSIH's Competitive Advantages?
- Proprietary cell-based technologies (if any).
- Established relationships with research institutions (if any).
- Specialized expertise in cell research and development.
- Strategic location in Beijing, China.
What Does GSIH Do?
General Steel Holdings, Inc., established in 2002 and based in Beijing, China, is involved in cell research, development, storage, and cell culture services. The company's operations are concentrated within the People's Republic of China. While the name suggests a focus on steel, the company's actual activities revolve around the biotechnology sector, specifically cell-based services. This discrepancy may reflect a historical business model that has since evolved. The company's services potentially cater to research institutions, healthcare providers, or pharmaceutical companies requiring cell-based solutions. Given its small size of 5 employees, General Steel Holdings likely operates on a relatively small scale, possibly focusing on niche areas within the broader cell research market. The company's competitive positioning is unclear without further data on its specific cell-based technologies and market share within China.
What Products and Services Does GSIH Offer?
- Engages in cell research and development.
- Provides cell storage services.
- Offers cell culture services.
- Operates within the People's Republic of China.
- Focuses on the biotechnology sector.
- Potentially caters to research institutions and healthcare providers.
How Does GSIH Make Money?
- Generates revenue through cell research and development projects.
- Earns income from cell storage services.
- Provides cell culture services for a fee.
- Potentially secures research grants and funding.
What Industry Does GSIH Operate In?
General Steel Holdings, Inc. operates in the Basic Materials sector, specifically within the steel industry, although its primary business is cell research and development. The global steel market is influenced by factors such as infrastructure development, automotive production, and construction activity. The cell research and development industry is experiencing growth due to advancements in biotechnology and increasing demand for cell-based therapies. Competitors in the steel industry include AFML (AFL Materials), CCOB (Cobra Acquisition Corporation), CLTH (Clothoid Biomedical Inc), CNTO (Cenntro Electric Group Limited), and DANR (Danimer Scientific Inc.). General Steel Holdings' positioning within these sectors is unclear given its small size and dual focus.
Who Are GSIH's Key Customers?
- Research institutions requiring cell-based solutions.
- Healthcare providers utilizing cell therapies.
- Pharmaceutical companies involved in drug development.
- Hospitals needing cell storage services.
Net buyingInsider Activity
The most recent 12 insider filings for General Steel Holdings, Inc. break down as 5 sales and 7 purchases. On net that is roughly 11.0M shares acquired (about $1.0M) — insiders putting money in tends to read as conviction.
GSIH Valuation & Market Position
With a 14K market cap, General Steel Holdings, Inc. sits in the micro-cap segment of the market.
ROE -20%Key Financial Metrics
Return on equity for General Steel Holdings, Inc. stands at -19.6%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -6.7%, showing how much profit it generates from its asset base. A current ratio of 0.50 means current liabilities exceed short-term assets, a liquidity point worth watching.
Company Profile
General Steel Holdings, Inc. operates in the Steel industry within the Basic Materials sector. It is headquartered in Beijing, CN. The company is led by CEO Baoning Shi. GSIH has traded publicly since 2004.
GSIH Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Focus on cell research and development.
- Location in Beijing, China.
- Potential for innovation in biotechnology.
- Cell storage and culture services
Bear Case
- Small size and limited resources.
- Negative profitability.
- High volatility.
- OTC market listing.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
GSIH Latest News
No recent news available for GSIH.
GSIH Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for GSIH.
Price Targets
Wall Street price target analysis for GSIH.
GSIH MoonshotScore
What does this score mean?
The MoonshotScore rates GSIH's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Baoning Shi
CEO
Baoning Shi is the CEO of General Steel Holdings, Inc. and manages a team of 5 employees. Information regarding Mr. Shi's detailed career history, educational background, and previous roles is not available. His leadership is focused on guiding the company's strategic direction in the cell research, development, storage, and cell culture service sectors within China.
Track Record: Due to limited information, Baoning Shi's specific achievements and strategic decisions as CEO are unknown. The company's current focus on cell research and development suggests a potential shift in business strategy under his leadership. Further information is needed to assess his impact on the company's performance and growth.
GSIH OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that General Steel Holdings, Inc. may not meet the minimum financial standards required for higher tiers like OTCQX or OTCQB. Companies in this tier often have limited financial disclosure, may be thinly traded, and carry a higher degree of risk compared to companies listed on major exchanges like the NYSE or NASDAQ. Investors should exercise extreme caution and conduct thorough due diligence before investing in OTC Other stocks.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure increases information asymmetry.
- Low trading volume and liquidity can lead to price volatility.
- Higher potential for fraud and manipulation.
- Lack of regulatory oversight compared to major exchanges.
- Going concern risk due to financial instability.
- Verify the company's legal registration and compliance status.
- Review available financial statements and assess their accuracy.
- Research the background and experience of the company's management team.
- Evaluate the company's business model and competitive landscape.
- Assess the company's cash flow and ability to meet its financial obligations.
- Understand the risks associated with the OTC market and the specific company.
- Consult with a qualified financial advisor.
- Consistent business operations since 2002.
- Focus on cell research and development.
- Headquarters located in Beijing, China.
- Active engagement in cell storage and culture services.
What Investors Ask About General Steel Holdings, Inc. (GSIH) — Basic Materials
What does General Steel Holdings, Inc. do?
General Steel Holdings, Inc. is involved in cell research, development, storage, and cell culture services within the People's Republic of China. While its name might suggest a focus on steel, the company primarily operates in the biotechnology sector, providing cell-based solutions. It caters to research institutions, healthcare providers, and pharmaceutical companies requiring specialized cell services. The company's business model revolves around generating revenue through research projects, storage fees, and culture services, contributing to advancements in regenerative medicine and personalized healthcare.
What do analysts say about GSIH stock?
There is currently no available analyst coverage for General Steel Holdings, Inc. due to its small market capitalization and OTC listing. Key valuation metrics such as revenue growth, profitability, and cash flow generation are essential to monitor. Investors should carefully assess the company's financial statements and business prospects to determine its intrinsic value. The company's growth potential hinges on its ability to commercialize its cell-based technologies and secure funding for research and development.
What are the main risks for GSIH?
General Steel Holdings, Inc. faces several risks, including intense competition from larger biotechnology companies with greater resources. Regulatory changes in China could impact the company's operations and profitability. Economic downturns may reduce research funding and healthcare spending, affecting demand for its services. The company's limited financial resources and negative profitability pose a significant challenge. Additionally, the OTC market listing exposes investors to high volatility, liquidity risks, and limited financial disclosure.
What are the key factors to evaluate for GSIH?
Evaluate GSIH on fundamentals, analyst consensus, and risk factors. Not financial advice.
How frequently does GSIH data refresh on this page?
GSIH prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven GSIH's recent stock price performance?
General Steel Holdings, Inc. (GSIH) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Focus on cell research and development. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider GSIH overvalued or undervalued right now?
Valuing General Steel Holdings, Inc. (GSIH) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying GSIH?
Before investing in General Steel Holdings, Inc. (GSIH), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available on the company's financials and operations.
- OTC market listing introduces additional risks and uncertainties.
- AI analysis pending for GSIH.